Software supports imaging research

Article

New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing

New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing technology for use in a multicenter clinical study to evaluate the rupture risk of AAAs. Reliable assessment of rupture risk in patients is important to reduce aneurysm-related mortality while avoiding unnecessary surgery. The company's optimized 3D reconstruction and finite element analysis technology generate patient-specific stress maps that illustrate aortic aneurysm wall stress. Metrx is also providing core lab services for the clinical trial through its data communication infrastructure, allowing participants to enter study data online.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.